We are live on ! Find out more
WINT

Windtree Therapeutics Inc
WINT

Delisted

WINT was delisted on the 4th of May, 2017.

Back to rankings

3 hedge funds and large institutions have $116K invested in Windtree Therapeutics Inc in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% less funds holding

Funds holding: 26 → 3 (-23)

96% less capital invested

Capital invested by funds: $2.63M → $116K (-$2.52M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 23

Holders
3
Holders Change
-23
Holders Change %
-88.46%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
23
Calls
$54K
Puts
–
Net Calls
+$54K
Net Calls Change
-$816K

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$67.8K

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$887K
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$524K
3
BBA
Baker Bros. Advisors
New York
-$291K
4
BlackRock
BlackRock
New York
-$224K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$173K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$112K +$67.8K +58,190 +20%
California Public Employees Retirement System
2
California Public Employees Retirement System
California
$4K – – –
MPWT
3
MassMutual Private Wealth & Trust
Connecticut
$7 – – –
BC
4
Broadfin Capital
New York
– -$887K -777,797 Closed
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
– -$524K -459,364 Closed
BBA
6
Baker Bros. Advisors
New York
– -$291K -254,973 Closed
BlackRock
7
BlackRock
New York
– -$224K -196,091 Closed
Vanguard Group
8
Vanguard Group
Pennsylvania
– -$173K -151,623 Closed
Geode Capital Management
9
Geode Capital Management
Massachusetts
– -$62K -54,795 Closed
Deutsche Bank
10
Deutsche Bank
Germany
– -$49K -43,340 Closed
Northern Trust
11
Northern Trust
Illinois
– -$19K -16,209 Closed
ARTA
12
A.R.T. Advisors
New York
– -$16K -14,300 Closed
SFWA
13
Summit Financial Wealth Advisors
Louisiana
– -$15K -13,000 Closed
WS
14
Wedbush Securities
California
– -$12K -10,784 Closed
UBS Group
15
UBS Group
Switzerland
– -$10K -8,444 Closed
Morgan Stanley
16
Morgan Stanley
New York
– -$5K -3,999 Closed
FDCDDQ
17
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$1.11K -978 Closed
Bank of America
18
Bank of America
North Carolina
– -$1K -610 Closed

WINT Hedge Fund Activity: Q2 2017 in Review

3 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q2 2017, worth a combined $116K — down 96% from $2.63M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of WINT and 0 opened new positions — a net loss of 23 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Sabby Management, adding an estimated $67.8K. The largest seller was Broadfin Capital, exiting entirely with an estimated $887K sold.

  • 3 institutional investors held Windtree Therapeutics Inc (WINT) as of Q2 2017, down from 26 in Q1 2017.
  • Funds reported $116K of Windtree Therapeutics Inc stock for Q2 2017, down 96% quarter-over-quarter.
  • 0 funds opened new Windtree Therapeutics Inc positions in Q2 2017 and 23 closed out, a net change of -23 holders.
  • The largest Windtree Therapeutics Inc buyer in Q2 2017 was Sabby Management, an estimated $67.8K added.
  • The largest Windtree Therapeutics Inc seller in Q2 2017 was Broadfin Capital, an estimated $887K sold.

Based on aggregated 13F filings for Q2 2017.